These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25155365)

  • 1. Apolipoprotein-containing lipoprotein subclasses and subclinical atherosclerosis in systemic lupus erythematosus.
    Kiani AN; Fang H; Akhter E; Quiroga C; Simpson N; Alaupovic P; Magder LS; Petri M
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):442-6. PubMed ID: 25155365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus.
    Kiani AN; Fang H; Magder LS; Petri M
    Rheumatology (Oxford); 2013 Nov; 52(11):2071-6. PubMed ID: 23955647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence and correlates of subclinical atherosclerosis among adults with low-density lipoprotein cholesterol <70 mg/dL: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Al Rifai M; Martin SS; McEvoy JW; Nasir K; Blankstein R; Yeboah J; Miedema M; Shea SJ; Polak JF; Ouyang P; Blumenthal RS; Bittencourt M; Bensenor I; Santos RD; Duncan BB; Santos IS; Lotufo PA; Blaha MJ
    Atherosclerosis; 2018 Jul; 274():61-66. PubMed ID: 29751286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.
    McMahon M; Skaggs BJ; Grossman JM; Sahakian L; Fitzgerald J; Wong WK; Lourenco EV; Ragavendra N; Charles-Schoeman C; Gorn A; Karpouzas GA; Taylor MB; Watson KE; Weisman MH; Wallace DJ; Hahn BH
    Arthritis Rheumatol; 2014 Jan; 66(1):130-9. PubMed ID: 24449580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III and Subclinical Atherosclerosis Measures: MESA (The Multi-Ethnic Study of Atherosclerosis).
    Aroner SA; Koch M; Mukamal KJ; Furtado JD; Stein JH; Tattersall MC; McClelland RL; Jensen MK
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29540426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein net charge is a risk factor for atherosclerosis in lupus patients independent of lipid concentrations.
    Rodríguez M; Guardiola M; Oliva I; Carles Vallvé J; Ferré R; Masana L; Parra S; Ribalta J; Castro A
    Int J Rheum Dis; 2019 Mar; 22(3):480-487. PubMed ID: 30450745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein B discordance with low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in relation to coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Cao J; Nomura SO; Steffen BT; Guan W; Remaley AT; Karger AB; Ouyang P; Michos ED; Tsai MY
    J Clin Lipidol; 2020; 14(1):109-121.e5. PubMed ID: 31882375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mikołajczyk TP; Osmenda G; Batko B; Wilk G; Krezelok M; Skiba D; Sliwa T; Pryjma JR; Guzik TJ
    Lupus; 2016 Jan; 25(1):18-27. PubMed ID: 26251402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher circulating levels of OxLDL % of LDL are associated with subclinical atherosclerosis in female patients with systemic lupus erythematosus.
    Ahmad HM; Sarhan EM; Komber U
    Rheumatol Int; 2014 May; 34(5):617-23. PubMed ID: 24101173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
    Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
    Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis.
    Knowlton N; Wages JA; Centola MB; Giles J; Bathon J; Quiroga C; Alaupovic P
    Arthritis Care Res (Hoboken); 2012 Jul; 64(7):993-1000. PubMed ID: 22337612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years.
    Kiani AN; Magder LS; Petri M
    Rheumatol Int; 2012 Sep; 32(9):2701-5. PubMed ID: 21792642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the Multi-Ethnic Study of Atherosclerosis.
    Gepner AD; Young R; Delaney JA; Tattersall MC; Blaha MJ; Post WS; Gottesman RF; Kronmal R; Budoff MJ; Burke GL; Folsom AR; Liu K; Kaufman J; Stein JH
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25596139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1.
    Park YJ; Shin YJ; Kim WU; Cho CS
    Lupus; 2014 Mar; 23(3):236-44. PubMed ID: 24531425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D.
    Basu A; Jenkins AJ; Stoner JA; Zhang Y; Klein RL; Lopes-Virella MF; Garvey WT; Schade DS; Wood J; Alaupovic P; Lyons TJ;
    J Lipid Res; 2018 May; 59(5):872-883. PubMed ID: 29576550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus.
    Ammirati E; Bozzolo EP; Contri R; Baragetti A; Palini AG; Cianflone D; Banfi M; Uboldi P; Bottoni G; Scotti I; Pirillo A; Grigore L; Garlaschelli K; Monaco C; Catapano AL; Sabbadini MG; Manfredi AA; Norata GD
    Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):751-9. PubMed ID: 24787906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus.
    Kiani AN; Post WS; Magder LS; Petri M
    Rheumatology (Oxford); 2011 Nov; 50(11):2071-9. PubMed ID: 21875880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear magnetic resonance lipoprotein subclasses and the APOE genotype influence carotid atherosclerosis in patients with systemic lupus erythematosus.
    Gonzàlez M; Ribalta J; Vives G; Iftimie S; Ferré R; Plana N; Guardiola M; Dallinga-Thie G; Masana L; Castro A
    J Rheumatol; 2010 Nov; 37(11):2259-67. PubMed ID: 20682673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regular physical activity and cardiovascular biomarkers in prevention of atherosclerosis in men: a 25-year prospective cohort study.
    Kwaśniewska M; Kostka T; Jegier A; Dziankowska-Zaborszczyk E; Leszczyńska J; Rębowska E; Orczykowska M; Drygas W
    BMC Cardiovasc Disord; 2016 Apr; 16():65. PubMed ID: 27044376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased circulating endothelial progenitor cells as an early risk factor of subclinical atherosclerosis in systemic lupus erythematosus.
    Castejon R; Jimenez-Ortiz C; Valero-Gonzalez S; Rosado S; Mellor S; Yebra-Bango M
    Rheumatology (Oxford); 2014 Apr; 53(4):631-8. PubMed ID: 24273021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.